Jose L. Callejas

Granada, AN, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Novel HLA class I and II insights into the pathogenesis of systemic sclerosis-associated interstitial lung disease.

Novel HLA class I and II insights into the pathogenesis of systemic sclerosis-associated interstitial lung disease.

Journal: Annals of the rheumatic diseases

Published: December 11, 2025

Novel pleiotropic loci links vascular and immune pathways in systemic sclerosis and primary Raynaud's phenomenon.

Novel pleiotropic loci links vascular and immune pathways in systemic sclerosis and primary Raynaud's phenomenon.

Journal: Rheumatology (Oxford, England)

Published: October 27, 2025

Novel pleiotropic loci link vascular and immune pathways in systemic sclerosis and primary Raynaud's phenomenon.

Novel pleiotropic loci link vascular and immune pathways in systemic sclerosis and primary Raynaud's phenomenon.

Journal: Rheumatology (Oxford, England)

Published: October 27, 2025

Distinct Effects of Complement C4A and C4B Copy Numbers in Systemic Sclerosis Serological and Clinical Subtypes.

Distinct Effects of Complement C4A and C4B Copy Numbers in Systemic Sclerosis Serological and Clinical Subtypes.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: June 26, 2025

Sex-specific autosomal susceptibility loci in systemic sclerosis: a genome-wide association study.

Sex-specific autosomal susceptibility loci in systemic sclerosis: a genome-wide association study.

Journal: The Lancet. Rheumatology

Published: June 10, 2025

Vitales project: Consensus on measuring health outcomes for better integrated management of patients with systemic lupus erythematosus.

Vitales project: Consensus on measuring health outcomes for better integrated management of patients with systemic lupus erythematosus.

Journal: Reumatologia clinica

Published: May 13, 2025

Assessing the MUC5B promoter variant in a large cohort of systemic sclerosis-associated interstitial lung disease.

Assessing the MUC5B promoter variant in a large cohort of systemic sclerosis-associated interstitial lung disease.

Journal: RMD open

Published: April 03, 2025

CD19 CAR-T cell therapy: a new dawn for autoimmune rheumatic diseases?

CD19 CAR-T cell therapy: a new dawn for autoimmune rheumatic diseases?

Journal: Frontiers in immunology

Published: September 27, 2024

Contribution of Telomere Length to Systemic Sclerosis Onset: A Mendelian Randomization Study.

Contribution of Telomere Length to Systemic Sclerosis Onset: A Mendelian Randomization Study.

Journal: International journal of molecular sciences

Published: October 03, 2023

The Effect of Body Fat Distribution on Systemic Sclerosis.

The Effect of Body Fat Distribution on Systemic Sclerosis.

Journal: Journal of clinical medicine

Published: September 16, 2022

Optimisation of tocilizumab therapy in giant cell arteritis. A multicentre real-life study of 471 patients.

Optimisation of tocilizumab therapy in giant cell arteritis. A multicentre real-life study of 471 patients.

Journal: Clinical and experimental rheumatology

Published: June 12, 2022

Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis.

Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis.

Journal: NPJ genomic medicine

Published: March 03, 2022

Showing 1-12 of 20

Last Updated: 09/26/2026